Skip to main content

Table 2 Outcome characteristics of patients with isolated pulmonary Candida spp. colonization (cohort 1)

From: Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects

 

Antifungal therapy (n = 102)

No antifungal therapy (n = 220)

p value

SOFA score (day 7)

6 (3; 9)

3 (2; 7)

0.003

 Lung

1 (1; 2)

1 (1; 2)

0.034

 Thrombocytes

1 (0; 2)

0 (0; 2)

0.236

 Liver

0 (0; 1)

0 (0; 0)

0.001

 Cardiovascular

0 (0; 3)

0 (0; 3)

0.033

 Renal

1 (0; 2)

1 (0; 2)

0.159

New pneumonia, n (%)

21 (20.6)

22 (10)

0.013

Sepsis, n (%)

   

 Sepsis/severe sepsis

27 (26.5)

26 (11.8)

0.002

 Septic shock

29 (28.4)

32 (14.5)

0.006

Duration of mechanical ventilation (h)

362 (199; 599)

160 (67; 284)

<0.001

Hospital stay (days)

31 (17; 53)

21 (12; 35)

<0.001

ICU stay (days)

20 (11; 29)

8 (4; 14)

<0.001

In-hospital mortality, n (%)

53 (52.0)

76 (34.5)

0.003

Discharge from hospital, n (%)

   

 Other hospital

24 (23.5)

47 (21.4)

0.667

 Rehabilitation clinic

19 (18.6)

42 (19.1)

1

 Home

6 (5.9)

49 (22.3)

<0.001

 Others

0 (0)

6 (2.7)

0.032

  1. Data are presented as median (25 %; 75 % quartile)
  2. SOFA Sequential Organ Failure Assessment, ICU intensive care unit